It will accelerate the development of improved crops for climate resilience
Bioseed — the hybrid seed business of diversified conglomerate DCM Shriram and the Manila-based International Rice Research Institute (IRRI) have signed a memorandum of agreement which allows the former access to the latter’s world-class research facilities and technical expertise for advancing biotechnology research.
Paresh Verma , Executive President, Bioseed South East Asia and Matthew Morell,IRRI Director General signed the agrrement. Accoording to MoU, Bioseed will join the international institute’s Two-Lines Study Group for hybrid rice development, the company said in a statement on Tuesday.
“It will enable Bioseed to leverage IRRI’s well-established research excellence to advance its biotechnology projects and accelerate the development of value-added food crops for farmers in the region,” said Verma.
“This agreement will help increase research capacity across South and South-East Asia and accelerate the development of improved crops for climate resilience and nutrition security,” said Remy Bitoun, Head of IRRI Tech Transfer.
